A Study in Healthy Men to Test How Well Different Doses of BI 1584862 Are Tolerated

NCT06148948 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 1584862
DRUG: Placebo

Sponsor

Boehringer Ingelheim